Ardelyx, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0396971071
USD
6.05
0.21 (3.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Ligand Pharmaceuticals, Inc.
ImmunityBio, Inc.
Ardelyx, Inc.
Revance Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Keros Therapeutics, Inc.
MannKind Corp.
Viking Therapeutics, Inc.
Morphic Holding, Inc.
ACELYRIN, Inc.
EQRx, Inc.

Why is Ardelyx, Inc. ?

1
Flat results in Mar 26
  • PRE-TAX PROFIT(Q) At USD -37.6 MM has Fallen at -148.04%
  • NET PROFIT(Q) At USD -37.6 MM has Fallen at -144.19%
  • INTEREST(9M) At USD 22.48 MM has Grown at 29.21%
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 67.59%, its profits have fallen by -58.7%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ardelyx, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Ardelyx, Inc.
67.59%
-0.10
66.28%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
121.91%
EBIT Growth (5y)
9.14%
EBIT to Interest (avg)
-14.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.92
Tax Ratio
1.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
79.26%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.05
EV to EBIT
-31.32
EV to EBITDA
-33.85
EV to Capital Employed
12.04
EV to Sales
3.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-38.45%
ROE (Latest)
-36.90%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -36.27 MM

NET PROFIT(HY)

Higher at USD -38.01 MM

RAW MATERIAL COST(Y)

Fallen by -13.91% (YoY

CASH AND EQV(HY)

Highest at USD 502.76 MM

-11What is not working for the Company
PRE-TAX PROFIT(Q)

At USD -37.6 MM has Fallen at -148.04%

NET PROFIT(Q)

At USD -37.6 MM has Fallen at -144.19%

INTEREST(9M)

At USD 22.48 MM has Grown at 29.21%

DEBT-EQUITY RATIO (HY)

Highest at -20.06 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.52 times

Here's what is working for Ardelyx, Inc.

Operating Cash Flow
Highest at USD -36.27 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Cash and Eqv
Highest at USD 502.76 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -13.91% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Ardelyx, Inc.

Pre-Tax Profit
At USD -37.6 MM has Fallen at -148.04%
over average net sales of the previous four periods of USD -15.16 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -37.6 MM has Fallen at -144.19%
over average net sales of the previous four periods of USD -15.4 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Debt-Equity Ratio
Highest at -20.06 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest
At USD 22.48 MM has Grown at 29.21%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Inventory Turnover Ratio
Lowest at 1.52 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio